Christopher Tapper
Director/Board Member at Microbiotica Ltd.
Network origin in Christopher Tapper first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Cambridge
226
| College/University | Other Consumer Services | 226 |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.
43
| Private Company | Investment Managers | 43 |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom.
9
| Holding Company | Biotechnology | 9 |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Tapper via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| APPLE INC. | Telecommunications Equipment | Corporate Officer/Principal Sales & Marketing | |
| MORGAN STANLEY | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| ARM HOLDINGS PLC | Information Technology Services | Director/Board Member Founder | |
| VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Top Institute Pharma
 Top Institute Pharma BiotechnologyHealth Technology Part of Center for Translational Molecular Medicine, Top Institute Pharma provides pharmaceutical research services. The company is based in Leiden, Netherlands. Top Institute Pharma was acquired by Center for Translational Molecular Medicine on June 09, 2015. | Biotechnology | Director/Board Member | |
| IXICO PLC | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| UK Medical Research Council | Corporate Officer/Principal Corporate Officer/Principal | ||
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
TD Securities, Inc.
 TD Securities, Inc. Investment Banks/BrokersFinance TD Securities, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of The Toronto-Dominion Bank (NYSE, TSE: TD). TD Securities provides a wide range of capital market products and services to corporate, government and institutional clients. Their services also include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The firm’s equity group provides research coverage of various sectors. Their fixed-income group provides a full range of underwriting sales and trading products for Canadian, US and European debt issuers and investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
Paradigm Capital, Inc.
 Paradigm Capital, Inc. Investment Banks/BrokersFinance Founded in 1999, Paradigm Capital, Inc. is an independent, institutional investment dealer headquartered in Toronto with an additional office in Calgary. They offer sector-based research, a strong distribution platform and select investment banking mandates. The firm focuses their research, distribution and investment banking efforts on several areas in the Canadian equity markets: growth, mining, energy and energy services. Paradigm is a member of the CIPF. | Investment Banks/Brokers | Analyst-Equity | |
| McGill University | College/University | Undergraduate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Founder Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| University of Bristol | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
| Loughborough University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Manchester Institute of Science & Technology | College/University | Graduate Degree Doctorate Degree | |
Oxford Capital Partners LLP
 Oxford Capital Partners LLP Investment ManagersFinance Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor Director/Board Member Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Sales & Marketing | |
| FRONTIER DEVELOPMENTS PLC | Recreational Products | Director/Board Member Director/Board Member Founder | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Founder | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman | |
Abcodia Ltd.
 Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| Chiroscience Ltd. | Corporate Officer/Principal Founder | ||
| Top Sector Life Sciences & Health | Director/Board Member | ||
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom. | Biotechnology | Chairman Director/Board Member Chief Investment Officer Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Founder Chairman Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder | |
| COGNETIVITY NEUROSCIENCES LTD. | Biotechnology | Director of Finance/CFO Compliance Officer | |
| Nefarma | Director/Board Member | ||
Sense Biodetection Ltd.
 Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
Cognetivity Ltd.
 Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Start Codon Ltd.
 Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder | |
Altacor Ltd.
 Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Pharmaceuticals: Major | Chairman Director of Finance/CFO |
Statistics
International
| United Kingdom | 28 |
| Netherlands | 7 |
| Switzerland | 6 |
| United States | 5 |
| Canada | 5 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 305 |
| Corporate Officer/Principal | 102 |
| Chairman | 81 |
| Undergraduate Degree | 64 |
| Private Equity Investor | 59 |
Most connected contacts
| Insiders | |
|---|---|
| Heiner Dreismann | 46 |
| Erik Langaker | 46 |
| Andrew Richards | 44 |
| Jonathan Milner | 26 |
| Charles Cotton | 24 |
| Johannes G. C. P. Schikan | 22 |
| Simon Laffin | 21 |
| Steven Leonard | 20 |
| Kieran Murphy | 19 |
| Robert Tansley | 18 |
| Ted Briscoe | 16 |
| Richard Friend | 16 |
| Timothy Sharpington | 15 |
| Gregory Winter | 14 |
| Michael Anstey | 14 |
- Stock Market
- Insiders
- Christopher Tapper
- Company connections
